First Time Loading...

Aveo Pharmaceuticals Inc
NASDAQ:AVEO

Watchlist Manager
Aveo Pharmaceuticals Inc Logo
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Watchlist
Price: 15 USD Market Closed
Updated: Jun 9, 2024

Aveo Pharmaceuticals Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aveo Pharmaceuticals Inc
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Total Liabilities
$72.4m
CAGR 3-Years
21%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities
$140.9B
CAGR 3-Years
1%
CAGR 5-Years
17%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$38.8B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$88B
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$5.4B
CAGR 3-Years
20%
CAGR 5-Years
24%
CAGR 10-Years
19%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$7.4B
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
22%

See Also

What is Aveo Pharmaceuticals Inc's Total Liabilities?
Total Liabilities
72.4m USD

Based on the financial report for Sep 30, 2022, Aveo Pharmaceuticals Inc's Total Liabilities amounts to 72.4m USD.

What is Aveo Pharmaceuticals Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-3%

Over the last year, the Total Liabilities growth was 25%. The average annual Total Liabilities growth rates for Aveo Pharmaceuticals Inc have been 21% over the past three years , -3% over the past five years .